Main Article Content

Abstract

Aim of the study


The present study is undertaken to study the cardiotonic activity and its protective role on heart by Paederia foetida belonging to the family Rubiaceae.


Materials and Methods


Paederia foetida leaf extracts with ethanol and hydro alcoholic (aq. Methanol) as solvents is prepared by maceration for 72h. Both the extracts have shown presence of cardiac glycosides, iridoids glycosides, alkaloids, flavonoids, tannins, phytosterols and aminoacids on phytochemical screening. These extracts PFEE and PFHE were screened for cardio tonic activity by "Isolated Frog Heart Perfusion Technique" and protective role studies by using Isoproterenol induced cardio toxicity in Wistar albino rats by administering PFEE and PFHE (200mg/kg) for a period of 14 days and Isoproterenol on 15th day (5.25mg/kg) and 16th day (8.5mg/kg) subcutaneously. Cardio protection was assessed by estimating the cardiac marker enzymes Aspartate dehydrogenase, Alanine dehydrogenase, Creatine Kinase MB, Lactate dehydrogenase and Total Protein levels in serum and heart tissues. Biochemical studies of assay of Na+K+ATPase, Ca2+ATPase and Mg2+ATPase were performed by administering the extracts 200mg/kg orally for a period of 7 days.


Results


Paederia foetida extracts has produced significant positive inotropic and negative chronotropic effect similar to that of standard drug digoxin. These effects were antagonized in presence of nifedipine but not with propranolol. A significant (p<0.05) decrease in membrane Na+K+ATPase and Mg2+ATPase and an increase in Ca2+ATPase on comparison to normal control, further confirmed its cardiotonic activity. The levels altered by isoproterenol were restored significantly (p<0.05) by the administration of the extracts both in serum and heart tissue levels. This activity can be attributed due to presence of particular cardiac glycosides and iridoids glycosides which can further processed.


Conclusion


Our work clearly shows that Paederia foetida possesses cardio tonic activity without altering the normal physiology of heart.

Keywords

Cardiotonic digoxin Paederia foetida membrane bound enzymes

Article Details

How to Cite
Tejaswi Burra, Raju Bairi, & Vijay kumar Kusuma. (2021). Evaluation of Cardiotonic and Cardioprotective Effects of Paederia foetida. International Journal of Research in Pharmacology & Pharmacotherapeutics, 4(2), 231-244. https://doi.org/10.61096/ijrpp.v4.iss2.2015.231-244

References

  1. 1. Burton L.L., Parker K.L. Goodman and Gilman’s Manual of Pharmacology and Therapeutics. Ed 12, The McGraw-Hill, New Delhi, 2008, pp.563-577.
  2. 2. Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB Jr. Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med. 284, 1971, 989-97.
  3. 3. Chauhan Khushbu, Patel Anar, Patel Mayuree, Macwan Carol, Solanki Roshni, Adeshara Subodh. Paederia foetida Linn. As a potential medicinal plant: A Review. Journal of Pharmacy Research. 2010; 3(12):3135-37.
  4. 4. Bairi Raju, C. Vijaya, A. Ramu. Evalution of cardiotonic activity of Peltophorum pterocarpum. IJP. 2011; 2 Suppl 1:1-6.
  5. 5. Bonting SL. Sodium-potassium activated adenosine triphosphatase and cation transport In: Bittar EE, editor. Membrane and ion transport. London: Wiley- Interscience; 1970.
  6. 6. Hjerten S, Pan H. Purification and characterization of two form of low affinity Ca 2+ATPase from erythrocyte membranes. Biochem Biophys Acta 1983; 728: 281-8.
  7. 7. Ohinishi T, Suzuki T, Suzuki Y, Ozawa K. Comparative study of plasma membrane Mg2+ATPase activities in normal, regenerating and malignant cells. Biochem Biophys Acta 1982; 684:67-74.
  8. 8. Periyathambi Thangappan Devika and Ponnian Staneley Mainzee Prince. (-) Epigallocatechin gallate(EGCG) prevents isoprenaline-induced cardiac toxicity by stabilizing cardiac marker enzymes and membrane-bound ATPases. JPP 2008; 60:125-33.
  9. 9. P. Muralidharan, G. Balamurugan and Pavan Kumar. Inotropic and cardio protective effects of Daucus carota Linn. on isoproterenol-induced myocardial infarction. Bangladesh J Pharmacol 2008; 3: 74-79.
  10. 10. Kitada Y, Narimatsu A, Suzuki R, Endoh M, Taira N. Does the positive ionotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? J Pharmacol Exp Ther 1987;243:639-45.
  11. 11. Tripathi K.D. ‘Essential of Medical Pharmacology’, Jaypee Brothers, New Delhi, Ed.5th. 2005. p.181-183.
  12. 12. Akera T, Brody TM. The role of Na+ K+ATPase in the ionotropic action of digitalis. Pharmacol Rev 1977; 29:187-220.
  13. 13. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992; 44: 377-99.
  14. 14. McGarry SJ, Williams AJ. Digoxin activates sarcoplasmic reticulum Ca2+ release channels: a possible role in cardiac ionotropy. Br J Pharmacol 1993; 108: 1043-50.
  15. 15. Wang SQ, Song LS, Lakatta EG, Cheng H. Ca2+ signaling between single L-type Ca2+ channels and rynodine receptors in heart cells. Nature 2001; 410: 592-6.
  16. 16. Fabiato A. Time and calcium dependence of activation and inactivation of calcium- induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinjee cell. J Gen Physiol 1985; 85:247-89.
  17. 17. Chen CL, Sangiah S, Patterson E, Berlin KD, Garrison GL, Dunn W, et al. Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+ K+ATPase, Mg 2+ATPase activities and contractile force. Res Commu Chem Pathol Pharmacol 1992; 78:3-16.